BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.
We create equitable access to capital by developing community partnerships and innovative financial products, services and tools that tackle systemic challenges and advance promising opportunities for residents and businesses in economically distressed communities.
The New York Foundation is a steadfast supporter of community organizing and advocacy. We believe that the resilience and vitality of New Yorkers is the city’s greatest resource, and we value the courage and experience of community groups and their leaders. In the ongoing struggle for equity, the Foundation supports grassroots initiatives that confront systemic barriers and inspire people to work toward a more just and inclusive city.
SeaChange—through its affiliated funds—makes flexible, impact-first loans to support the real estate, working capital, and expansion capital needs of nonprofits working in Greater New York City. Our funds provide a level of flexibility and risk tolerance unavailable from conventional lenders. We seek to support groups whose financing needs cannot be met by traditional sources of financing including commercial banks and CDFIs.
